| Χρονικό πλαίσιο | Προβλεπόμενη τιμή | Το παρελθόν | Ιστορικός | Διορατικότητα |
|---|---|---|---|---|
| Αύριο | $2.78 ▼ -0.88% | Εχθές | $2.81 ▲ +0.37% | Tomorrow's Spero Therapeutics Inc. Common Stock (SPRO) setup is anchored to $2.80 and targets $2.78 (-0.88%). The near-term read is downside; watch $2.88 / $2.72 because daily realized volatility is about 4.56%. |
Tomorrow's Spero Therapeutics Inc. Common Stock (SPRO) setup is anchored to $2.80 and targets $2.78 (-0.88%). The near-term read is downside; watch $2.88 / $2.72 because daily realized volatility is about 4.56%. | ||||
| Εβδομάδα | $2.72 ▼ -2.75% | Την περασμένη εβδομάδα | $2.83 ▲ +1.16% | The 7-day Spero Therapeutics Inc. Common Stock model moves from $2.83 to $2.72 (-2.75%). It gives downside momentum context for this stock, so breaks around $2.88 / $2.72 matter more than a single tick. |
The 7-day Spero Therapeutics Inc. Common Stock model moves from $2.83 to $2.72 (-2.75%). It gives downside momentum context for this stock, so breaks around $2.88 / $2.72 matter more than a single tick. | ||||
| Μήνας | $2.64 ▼ -5.86% | τον περασμένο μήνα | $2.87 ▲ +2.46% | The 1-month Spero Therapeutics Inc. Common Stock target is $2.64 (-5.86%), compared with the live reference near $2.80. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Spero Therapeutics Inc. Common Stock target is $2.64 (-5.86%), compared with the live reference near $2.80. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Ετος | $2.51 ▼ -10.51% | Πέρυσι | $2.92 ▲ +4.42% | The 1-year Spero Therapeutics Inc. Common Stock scenario points to $2.51 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Spero Therapeutics Inc. Common Stock scenario points to $2.51 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Χρόνια | $2.20 ▼ -21.43% | Πριν 5 Χρόνια | $3.05 ▲ +9.00% | The 5-year Spero Therapeutics Inc. Common Stock view is $2.20 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Spero Therapeutics Inc. Common Stock view is $2.20 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Δείκτης | Αξία | Σύνθημα |
|---|---|---|
| Price | $2.80 | Mid |
| Daily Change | -1.41% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 60% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $2.80 | Daily Change | -1.41% |
| Market Cap | $162.10M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.